Laxmi Dental IPO Approved by SEBI: Rs 150 Crore Fresh Issue
By Rediff Money Desk, New Delhi Dec 16, 2024 17:20
Laxmi Dental receives SEBI approval for IPO, raising Rs 150 crore through fresh issue and an offer for sale. The dental products company plans to invest in subsidiary Bizdent Devices and purchase new machinery.

Illustration: Uttam Ghosh/Rediff.com
New Delhi, Dec 16 (PTI) Dental products company Laxmi Dental Ltd has received Sebi's go-ahead to raise funds through an initial public offering (IPO), an update with the markets regulator showed on Monday.
The proposed IPO is a combination of a fresh issue of equity shares worth Rs 150 crore and an offer for sale (OFS) of 1.28 crore shares by promoters and other shareholders, according to the draft red herring prospectus (DRHP).
As a part of the OFS, investor OrbiMed Asia II Mauritius Ltd will offload shares of the IPO-bound company.
Besides, the company may consider raising Rs 30 crore in a pre-IPO placement round. If such placement is completed, the fresh issue size will be reduced.
As per the update, Laxmi Dental, which filed preliminary IPO papers with Sebi in September, obtained its observation on December 12.
In Sebi's parlance, obtaining observation means its go-ahead to float the public issue.
Going by the draft papers, proceeds from the fresh issue will be kept aside for investment in subsidiary Bizdent Devices, purchase of new machinery for the company, payment of debt and for general corporate purposes.
Laxmi Dental, an end-to-end integrated dental products company, has a comprehensive portfolio that includes custom-made crowns and bridges, branded dental products such as aligner solutions and paediatric dental products.
Nuvama Wealth Management, Motilal Oswal Investment Advisors and SBI Capital Markets are book-running lead managers to the issue.
On the other hand, the regulator returned the IPO document of Anlon Healthcare on December 9. The draft offer document was filed in October, the update showed.
The proposed IPO is a combination of a fresh issue of equity shares worth Rs 150 crore and an offer for sale (OFS) of 1.28 crore shares by promoters and other shareholders, according to the draft red herring prospectus (DRHP).
As a part of the OFS, investor OrbiMed Asia II Mauritius Ltd will offload shares of the IPO-bound company.
Besides, the company may consider raising Rs 30 crore in a pre-IPO placement round. If such placement is completed, the fresh issue size will be reduced.
As per the update, Laxmi Dental, which filed preliminary IPO papers with Sebi in September, obtained its observation on December 12.
In Sebi's parlance, obtaining observation means its go-ahead to float the public issue.
Going by the draft papers, proceeds from the fresh issue will be kept aside for investment in subsidiary Bizdent Devices, purchase of new machinery for the company, payment of debt and for general corporate purposes.
Laxmi Dental, an end-to-end integrated dental products company, has a comprehensive portfolio that includes custom-made crowns and bridges, branded dental products such as aligner solutions and paediatric dental products.
Nuvama Wealth Management, Motilal Oswal Investment Advisors and SBI Capital Markets are book-running lead managers to the issue.
On the other hand, the regulator returned the IPO document of Anlon Healthcare on December 9. The draft offer document was filed in October, the update showed.
Source: PTI
Read More On:
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 9.12 ( -3.70)
- 28487876
- Srestha Finvest
- 0.65 ( -5.80)
- 17244407
- Murae Organisor
- 1.85 (+ 4.52)
- 16017942
- Quadrant Televenture
- 0.52 (+ 4.00)
- 15423224
- Sunshine Capital
- 0.86 ( -4.44)
- 12894409
MORE NEWS
Nirmata Raises USD 9.6 Mn from Peak XV's Surge
Nirmata, a cloud startup, raised USD 9.6 million in funding led by Peak XV's Surge. The...

Nykaa Q3 Profit Surges 51% to Rs 26.4 cr
Nykaa's Q3 profit rose 51% to Rs 26.4 crore, driven by strong revenue growth across its...

Syngene CEO Jonathan Hunt Steps Down, Peter...
Syngene International's MD & CEO Jonathan Hunt has stepped down, with Peter Bains...